Avivagen Inc.
VIVXF
$0.00
$0.000.00%
OTC PK
| 07/31/2023 | 04/30/2023 | 01/31/2023 | 10/31/2022 | 07/31/2022 | |
|---|---|---|---|---|---|
| Net Income | -3.46M | -4.24M | -4.35M | -4.72M | -5.10M |
| Total Depreciation and Amortization | 45.70K | 57.50K | 62.30K | 68.10K | 75.50K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.58M | 1.55M | 1.28M | 1.48M | 1.37M |
| Change in Net Operating Assets | 1.28M | 1.13M | 825.60K | 752.70K | 671.20K |
| Cash from Operations | -551.00K | -1.49M | -2.18M | -2.41M | -2.99M |
| Capital Expenditure | -- | -- | -- | -- | 4.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | 4.00K |
| Total Debt Issued | 0.00 | -4.46M | 0.00 | 0.00 | 13.30K |
| Total Debt Repaid | -50.00K | -608.90K | -5.98M | -5.98M | -5.99M |
| Issuance of Common Stock | 634.50K | 4.42M | 7.27M | 7.27M | 6.66M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -327.90K | 1.15M | 730.50K | 705.80K | 620.30K |
| Cash from Financing | 195.10K | 379.20K | 1.58M | 1.56M | 1.03M |
| Foreign Exchange rate Adjustments | -400.00 | 3.10K | 2.10K | -4.90K | 20.70K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -356.20K | -1.11M | -592.60K | -862.80K | -1.93M |